|
Index of reports
> Cases with Nausea (32)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 32 Next >>
Possible Intron A side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-02
Patient: male, weighing 76.7 kg (168.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Therapy Cessation, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a physician from United States on 2012-07-31
Patient: male, weighing 112.0 kg (246.4 pounds)
Reactions: Weight Decreased, Abdominal Pain, Nausea, Chills, Dysstasia, Fatigue, Diarrhoea, Dehydration, Dizziness, Fluid Intake Reduced
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-30
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Fatigue, Nausea, Abnormal Behaviour, Cognitive Disorder, Memory Impairment, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 83.6 kg (183.9 pounds)
Reactions: Vomiting, Diarrhoea, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-20
Patient: male, weighing 81.6 kg (179.5 pounds)
Reactions: Back Pain, Pain in Extremity, Nausea
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a physician from United States on 2012-07-20
Patient: female, weighing 83.6 kg (183.9 pounds)
Reactions: Vomiting, Diarrhoea, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-18
Patient: male, weighing 102.7 kg (225.9 pounds)
Reactions: Tumour Necrosis, Atelectasis, Nausea, Retching, Headache, Axillary Mass, Cyst, Cholelithiasis, Proteinuria, Hypoxia, Pancreatitis, Abscess, Lung Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a physician from United States on 2012-07-12
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Confusional State, Vomiting, Nausea, Urinary Tract Infection, Autoimmune Disorder, Malaise, Dehydration, Hypophagia, Feeling Abnormal, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a physician from United States on 2012-07-12
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Confusional State, Vomiting, Malaise, Nausea, Urinary Tract Infection, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-27
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Vomiting, Nausea, Dehydration, Urinary Tract Infection, Hypophagia, Feeling Abnormal, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22
Patient: male
Reactions: Nausea, Chills, Pain, Radiation Skin Injury, Pyrexia, Treatment Noncompliance, Rash Pruritic, Fatigue, Lymph Node Pain, Liver Function Test Abnormal, Swelling, Asthenia, Lymphoedema, Post Procedural Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A (Interferon Alfa-2B)
Dosage: 40 miu;;iv, 30 miu,,iv,
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A (Interferon Alfa-2B)
Dosage: 40 miu;;iv, 30 miu,,iv,
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2011-12-05
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-23
Patient: female
Reactions: Renal Function Test Abnormal, Food Poisoning, Pain, Chills, Blood Count Abnormal, Headache, Pyrexia, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Feeling of Body Temperature Change, Blood Pressure Abnormal, Blood Creatinine Increased, Lethargy, Blood Test Abnormal, Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Nausea, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2012-05-07
Other drugs received by patient: Micardis; Amlodipine Besylate; Amlodipine Besylate; Atiacid; Zofran; Acetaminophen
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-17
Patient: male
Reactions: Nausea, Pain, Chills, Pyrexia, Thermal Burn, Rash Pruritic, Hepatic Enzyme Increased, Asthenia, Lymphoedema, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-12-05
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24
Patient: female
Reactions: Weight Decreased, Muscle Atrophy, Pruritus, Skin Exfoliation, Loss of Consciousness, Tongue Disorder, Skin Discolouration, Dizziness, Musculoskeletal Stiffness, Depression, Decreased Appetite, Psychomotor Hyperactivity, Nausea, Rash, DRY Skin, Amnesia, Syncope, Dysphonia, Insomnia, Alopecia, Mental Disorder, Memory Impairment
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2011-10-13
End date: 2012-04-05
PEG-Intron
Indication: Hepatitis C
Start date: 2001-01-01
End date: 2001-03-01
PEG-Intron
Indication: Hepatitis C
Start date: 2011-10-13
End date: 2012-04-05
Intron A
Indication: Hepatitis C
Start date: 2000-01-01
End date: 2000-06-01
Telaprevir
Indication: Hepatitis C
Start date: 2011-10-13
End date: 2012-04-05
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12
Patient: male
Reactions: Dyspnoea, Nausea, Flatulence, Headache, Abdominal Pain Upper, Dysgeusia, Fatigue, Dyspepsia, Insomnia, Thyroid Disorder, Abdominal Distension, Hypothyroidism
Drug(s) suspected as cause:
Intron A
Indication: Hepatitis C
Start date: 1998-01-02
End date: 1998-11-27
PEG-Intron
Indication: Hepatitis C
Start date: 2012-01-13
PEG-Intron
Indication: Hepatitis C
Start date: 2001-04-06
End date: 2003-04-04
Victrelis
Indication: Hepatitis C
Start date: 2012-02-11
Pegasys
Indication: Hepatitis C
Start date: 2009-01-02
End date: 2009-11-27
Ribavirin
Start date: 2009-01-02
End date: 2009-11-27
Ribavirin
Start date: 2001-04-06
End date: 2003-04-04
Ribavirin
Start date: 2012-01-12
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-12
Patient: female
Reactions: Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Renal Function Test Abnormal, Nausea, Chills, Food Poisoning, Headache, Rash, Lower Respiratory Tract Infection, Laboratory Test Abnormal, Fatigue, Liver Function Test Abnormal, White Blood Cell Count Increased, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Other drugs received by patient: Micardis; Antiacid; Zofran; Acetaminophen
Possible Intron A side effects in male
Reported by a physician from United States on 2012-03-21
Patient: male, weighing 102.7 kg (225.9 pounds)
Reactions: Tumour Necrosis, Abdominal Pain, Atelectasis, Retching, Nausea, Axillary Mass, Cyst, Cholelithiasis, Proteinuria, Pancreatitis, Hypoxia, Abscess, Lung Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a individual with unspecified qualification from United States on 2012-03-20
Patient: male, weighing 102.7 kg (225.9 pounds)
Reactions: Atelectasis, Tumour Necrosis, Abdominal Pain, Exposure To Communicable Disease, Subcutaneous Abscess, Retching, Nausea, Cyst, Headache, Axillary Mass, Cholelithiasis, Proteinuria, Pancreatitis, Hypoxia, Lung Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a individual with unspecified qualification from United States on 2012-03-13
Patient: male, weighing 102.7 kg (225.9 pounds)
Reactions: Abdominal Pain, Retching, Nausea, Proteinuria, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a individual with unspecified qualification from United States on 2012-03-13
Patient: male, weighing 102.7 kg (225.9 pounds)
Reactions: Abdominal Pain, Exposure To Communicable Disease, Nausea, Proteinuria, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-02
Patient: male
Reactions: Nausea, Pain, Chills, Radiation Skin Injury, Pyrexia, Thermal Burn, Rash Pruritic, Fatigue, Liver Function Test Abnormal, Asthenia, Post Procedural Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-12-05
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-02-07
Patient: female
Reactions: Dyspnoea, Cardiac Flutter, Nausea, Body Temperature Increased, Chills, Headache, Rash, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Other drugs received by patient: Micardis; Zofran; Antiacid; Acetaminophen
Possible Intron A side effects in female
Reported by a physician from United States on 2012-01-13
Patient: female, weighing 90.1 kg (198.2 pounds)
Reactions: Vomiting, Nausea, Dehydration, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-11
Patient: female, weighing 90.1 kg (198.2 pounds)
Reactions: Vomiting, Nausea, Dehydration, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-19
Patient: female
Reactions: Dyspnoea, Cardiac Flutter, Nausea, Chills, Headache, Rash, Fatigue, Liver Function Test Abnormal, Lethargy
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-06
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-03
Other drugs received by patient: Micardis; Zofran; Antacid; Acetaminophen
Possible Intron A side effects in female
Reported by a physician from United States on 2011-11-28
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Refusal of Treatment by Patient, Fatigue, Nausea, Abnormal Behaviour, Cognitive Disorder, Memory Impairment, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in female
Reported by a physician from United States on 2011-11-14
Patient: female, weighing 57.7 kg (126.9 pounds)
Reactions: Fatigue, Nausea, Urinary Tract Infection, Neutropenia, Asthenia
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-14
Patient: male
Reactions: Weight Decreased, Nausea, Alopecia, Skin Disorder, Hepatic Cirrhosis
Drug(s) suspected as cause:
Intron A
Dosage: tiw
Indication: Hepatitis C
Start date: 2002-01-04
End date: 2002-06-28
Intron A
Dosage: tiw
Indication: Hepatitis C
Start date: 2011-10-14
Ribavirin
Indication: Hepatitis C
Start date: 2011-10-14
Ribavirin
Indication: Hepatitis C
Start date: 2002-01-04
End date: 2002-06-28
Possible Intron A side effects in 22 year old female
Reported by a physician from Canada on 2011-11-14
Patient: 22 year old female, weighing 94.2 kg (207.2 pounds)
Reactions: Metastatic Malignant Melanoma, Vomiting, Nausea, Tachycardia, Oropharyngeal Pain, Headache, Throat Tightness, Metastases To Lymph Nodes
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 39 miu; iv; iv
Indication: Malignant Melanoma
Start date: 2010-02-08
End date: 2010-02-08
Intron A
Dosage: 39 miu; iv; iv
Indication: Malignant Melanoma
Start date: 2010-02-09
Other drugs received by patient: Acetaminophen
Possible Intron A side effects in female
Reported by a physician from United States on 2011-11-07
Patient: female, weighing 57.7 kg (126.9 pounds)
Reactions: Fatigue, Nausea, Urinary Tract Infection, Neutropenia, Asthenia
Drug(s) suspected as cause:
Intron A
Page 1 Next >>
|
